Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies. | Chembiochem | 2022 | 35972230 | PubTator, text mining | PubMed |
| Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19. | Acta Pharm Sin B | 2022 | 35968270 | PubTator, text mining | PubMed |
| A recombinant murine-like rotavirus with Nano-Luciferase expression reveals tissue tropism, replication dynamics, and virus transmission. | Front Immunol | 2022 | 35967392 | PubTator, text mining | PubMed |
| Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity. | Front Microbiol | 2022 | 35966679 | PubTator, text mining | PubMed |
| Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins. | Front Cell Neurosci | 2022 | 35966209 | PubTator, text mining | PubMed |
| Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination. | Int Immunopharmacol | 2022 | 35963158 | PubTator, text mining | PubMed |
| Porcine epidemic diarrhea virus strain FJzz1 infection induces type I/III IFNs production through RLRs and TLRs-mediated signaling. | Front Immunol | 2022 | 35958569 | PubTator, text mining | PubMed |
| COVID-19 metabolism: Mechanisms and therapeutic targets. | MedComm (2020) | 2022 | 35958432 | PubTator, text mining | PubMed |
| Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections. | Int J Mol Sci | 2022 | 35955436 | PubTator, text mining | PubMed |
| Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein. | Int J Biol Macromol | 2022 | 35952818 | PubTator, text mining | PubMed |
| Viral-mediated activation and inhibition of programmed cell death. | PLoS Pathog | 2022 | 35951530 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion. | Microb Pathog | 2022 | 35944840 | PubTator, text mining | PubMed |
| The mechanism of RNA capping by SARS-CoV-2. | Nature | 2022 | 35944563 | PubTator, text mining | PubMed |
| Two Years into the COVID-19 Pandemic: Lessons Learned. | ACS Infect Dis | 2022 | 35940589 | PubTator, text mining | PubMed |
| Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments. | J Virol | 2022 | 35938869 | PubTator, text mining | PubMed |
| Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection. | Front Cell Infect Microbiol | 2022 | 35937687 | PubTator, text mining | PubMed |
| Recent advances in the study of NADC34-like porcine reproductive and respiratory syndrome virus in China. | Front Microbiol | 2022 | 35935186 | PubTator, text mining | PubMed |
| Liver damage in the context of SARS-CoV-2. Covid-19 treatment and its effects on the liver. | J Med Life | 2022 | 35928369 | PubTator, text mining | PubMed |
| Role of transcription factors in porcine reproductive and respiratory syndrome virus infection: A review. | Front Microbiol | 2022 | 35928151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=43